Cryopreservation of peripheral blood stem cell: The influence of cell concentration on cellular and hematopoietic recovery

Transfusion

Volumn 50, Issue 11, 2010, Pages 2402-2412

  Alencar, Sibelle ^a   Garnica, Márcia ^a   Luiz, Ronir R ^a   Nogueira, Carmen M ^a   Borojevic, Radovan ^a   Maiolino, Angelo ^a   Dutra, Hélio S ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CARBOPLATIN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CELL VIABILITY; CHILD; COLONY FORMING UNIT GM; CONTROLLED STUDY; CRYOPRESERVATION; EWING SARCOMA; FEMALE; GERM CELL TUMOR; HEMATOPOIETIC CELL; HODGKIN DISEASE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYELOID LEUKEMIA; NEUTROPHIL; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; RETROSPECTIVE STUDY; SCHOOL CHILD; STEM CELL MOBILIZATION;

BLOOD PRESERVATION; CELL COUNT; CELL SURVIVAL; CRYOPRESERVATION; GRAFT SURVIVAL; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; KAPLAN-MEIER ESTIMATE; NEUTROPHILS; PROPORTIONAL HAZARDS MODELS; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS;

EID: 78349278462     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02743.x     Document Type: Article

References (27)

1. Bakken AM,. Cryopreserving human peripheral blood progenitor cells. Curr Stem Cell Res Ther 2006; 1: 47 -54.
2. Specchia G, Pastore D, Mestice A, Liso A, Carluccio P, Leo M, Casanova M, Sibilla S, Giannoccaro M, Liso V,. Early and long-term engraftment after autologous peripheral stem cell transplantation in acute myeloid leukemia patients. Acta Haematol 2006; 116: 229 -37.
3. Mehta J, Singhal S,. Current status of autologous haematopoetic stem cell transplantation in myeloma. Bone Marrow Transplant 2008; 42 Suppl 1: S28 -S34.
4. Lucidarme N, Valteau-Couanet D, Oberlin O, Couanet D, Kalifa C, Beaujean F, Lapierre V, Hartmann O,. Phase II study of high-dose thiotepa and haematopoetic stem cell transplantation in children with solid tumors. Bone Marrow Transplant 1998; 22: 535 -40.
5. Attal M, Harousseau JL,. Role of autologous stem-cell transplantation in multiple myeloma. Best Pract Res Clin Haematol 2007; 20: 747 -59.
6. Hénon PR,. Peripheral blood stem cell transplantations: past, present and future. Stem Cells 1993; 11: 154 -72.
7. Jansen J, Thompson JM, Dugan MJ, Nolan P, Wiemann MC, Birhiray R, Henslee-Downey PJ, Akard LP,. Peripheral blood progenitor cell transplantation. Ther Apher 2002; 6: 5 -14.
8. Kroschinsky F, Hlig K, Ehninger G,. The role of pegfilgrastim in mobilization of haematopoetic stem cells. Transfus Apher Sci 2008; 38: 237 -44.
9. Windrum P, Morris TC, Drake MB, Niederwieser D, Ruutu T, EBMT Chronic Leukaemia Working Party Complications Subcommittee. Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centers. Bone Marrow Transplant 2005; 36: 601 -3.
10. Berz D, McCormack EM, Winer ES, Colvin GA, Quesenberry PJ,. Cryopreservation of haematopoetic stem cells. Am J Hematol 2007; 82: 463 -72.
11. Alessandrino P, Bernasconi P, Caldera D, Colombo A, Bonfichi M, Malcovati L, Klersy C, Martinelli G, Maiocchi M, Pagnucco G, Varettoni M, Perotti C, Bernasconi C,. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. Bone Marrow Transplant 1999; 23: 533 -7.
12. Akk k CA, Liseth K, Nesthus I, Lkeland T, Tefre K, Bruserud O, Abrahamsen JF,. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable haematopoetic reconstitution after transplantation. Transfusion 2008; 48: 877 -83.
13. Halle P, Tournilhac O, Knopinska-Posluszny W, Kanold J, Gembara P, Boiret N, Rapatel C, Berger M, Travade P, Angielski S, Bonhomme J, Deméocq F,. Uncontrolled-rate freezing and storage at -80 degrees C. with only 3.5-percent DMSO in cryoprotective solution for 109 autologous peripheral blood progenitor cell transplantations. Transfusion 2001; 41: 667 -73.
14. Rowley SD, Bensinger WI, Gooley TA, Buckner CD,. Effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation. Blood 1994; 83: 2731 -6.
15. Cabezudo E, Dalmases C, Ruz M, Sanchez JA, Torrico C, Sola C, Querol S, García J,. Leukapheresis components may be cryopreserved at high cell concentrations without additional loss of HPC function. Transfusion 2000; 40: 1223 -7.
16. Martin-Henao GA, Torrico C, Azqueta C, Amill B, Querol S, Garcia J,. Cryopreservation of haematopoetic progenitor cells from apheresis at high cell concentrations does not impair the haematopoetic recovery after transplantation. Transfusion 2005; 45: 1917 -24.
17. Perseghin P, Epis R, Vigano M, Malacrida A, Pastorini A, Camerone G,. Satisfactory recovery and viability of stem cells cryopreserved at high cell concentration. Transfusion Science 1997; 18: 399 -403.
18. Kawano Y, Lee CL, Watanabe T, Abe T, Suzuya H, Okamoto Y, Makimoto A, Nakagawa R, Watanabe H, Takaue Y,. Cryopreservation of mobilized blood stem cells at a higher cell concentration without the use of a programmed freezer. Ann Hematology 2004; 83: 50 -4.
19. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I,. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 1996; 5: 213 -26.
20. Gratama JW, Chin-Yee IH, Sutherland DR,. Isotype controls in the analysis of lymphocytes and CD34+ stem and progenitor cells by flow cytometry-time to let go! Cytometry 1998; 34: 280 -3.
21. Gratama JW, Orfao A, Barnett D, Brando B, Huber A, Janossy G, Johnsen HE, Keeney M, Marti GE, Preijers F, Rothe G, Serke S, Sutherland DR, Van der Schoot CE, Schmitz G, Papa S,. Flow cytometric enumeration of CD34+ haematopoetic stem and progenitor cells. European Working Group on Clinical Cell Analysis. Cytometry 1998; 34: 128 -42.
22. Immunocompromised Host Society. The design, analysis and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. J Infect Dis 1990; 161: 397 -401.
23. Bucaneve G, Micozzi A, Menichetti F, Martino P, Dionisi MS, Martinelli G, Allione B, D'Antonio D, Buelli M, Nosari AM, Cilloni D, Zuffa E, Cantaffa R, Specchia G, Amadori S, Fabbiano F, Deliliers GL, Lauria F, Fo R, Del Favero A, Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Infection Program. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med 2005; 353: 977 -87.
24. Pérez-Simón JA, Martín A, Caballero D, Corral M, Nieto MJ, Gonzalez M, Vazquez L, López-Berges C, Cañizo MC, Mateos MV, Orfao A, San Miguel JF,. Clinical significance of CD34+ cell dose in long-term engraftment following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1999; 24: 1279 -83.
25. Jillella AP, Ustun C,. What is the optimum number of CD34+ peripheral blood stem cells for an autologous transplant? Stem Cells Dev 2004; 13: 598 -606.
26. Yang H, Acker JP, Cabuhat M, Letcher B, Larratt L, Mcgann LE,. Association of post-thaw viable CD34+ cells and CFU-GM with time to hematopoietic engraftment. Bone Marrow Transplant 2005; 35: 881 -88.
27. Burger SR, Kadidlo D, Mccullough J,. Improved progenitor assay standardization using peripheral blood progenitor cells from a donor treated with granulocyte-colony-stimulating factor. Transfusion 1999; 39: 451 -6.